All stock lists
CDT Equity Inc. (NASDAQ:CDT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.09-0.04 (-27.00%)
Insider Score
––Not scored
CDT Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CDT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 29, 2026 | Dec 31, 2025 | Sep 28, 2025 | Jun 29, 2025 | Mar 30, 2025 |
| Revenue | 750.16 M | 696.38 M | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 449.13 M | 438.29 M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 301.03 M | 258.09 M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.70 M | 138.65 M | 20.41 M | 5.50 M | 3.09 M | 2.70 M |
| R&D Expense | 32.91 M | 30.09 M | 746.00 K | 1.53 M | 1.86 M | 916.00 K |
| Operating Expenses | 183.66 M | 180.13 M | 21.16 M | 7.03 M | 4.95 M | 3.62 M |
| Operating Income | 117.37 M | 77.96 M | -21.16 M | -7.03 M | -4.95 M | -3.62 M |
| Pretax Income | 85.20 M | 62.77 M | -21.32 M | -7.12 M | -6.03 M | -4.75 M |
| Tax Provision | 16.67 M | 11.74 M | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 68.54 M | 51.03 M | -21.32 M | -7.12 M | -6.03 M | -4.75 M |
| EPS (Basic) | -8.71 | -55.62 | -2314.41 | -3290.26 | -10925.00 | -36695.00 |
| EPS (Diluted) | -8.71 | -55.62 | -2314.41 | -3290.26 | -10925.00 | -36695.00 |
| Shares Outstanding | 533.00 K | 73.05 K | 9.21 K | 2.16 K | 552.00 | 130.00 |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.